Seminars in Hematology
Volume 40, Issue 1 , Pages 13-21 , January 2003

Prognostic factors in chronic myeloid leukemia: Allografting

  • Image Result

    Survival of patients with HSCT depending on disease stage at time of transplant. CP, chronic phase; AP, accelerated phase; BC, blast crisis.

    Survival of patients with HSCT depending on disease stage at time of transplant. CP, chronic phase; AP, accelerated phase; BC, blast crisis.

  • Image Result

    Survival and transplant related mortality depending on EBMT risk score. Reprinted with permission from Elsevier Science. (The Lancet17).

    Survival and transplant related mortality depending on EBMT risk score. Reprinted with permission from Elsevier Science. (The Lancet17).

  • Image Result

    Influence of GvHD on outcome. (A) Influence of aGvHD grade (0, I, II, III, IV) between day 100 and 3 years. (B) Influence of cGvHD grade (none, limited, extensive) on survival beyond 3 years post-tran

    Influence of GvHD on outcome. (A) Influence of aGvHD grade (0, I, II, III, IV) between day 100 and 3 years. (B) Influence of cGvHD grade (none, limited, extensive) on survival beyond 3 years post-transplant. (Reprinted with permission from: Gratwohl A, Brand R, Apperley J, et al. Graft-versus-host disease and outcome in HLA-identical sibling transplants for chronic myeloid leukemia. Blood 2002;100:3877-3886. Copyright American Society of Hematology, used by permission.)

☆ Address reprint requests to Prof Dr Alois Gratwohl, Division of Hematology, Department of Internal Medicine, Kantonsspital Basel, CH-4031 Basel, Switzerland.

PII: S0037-1963(03)70039-0

Seminars in Hematology
Volume 40, Issue 1 , Pages 13-21 , January 2003

Article Tools

* Image Usage & Resolution